-
Dual GLP-1/GIP Receptor Agonist BGM0504Product Name: Dual GLP-1/GIP receptor agonist BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
BGM0504 Injection GLP-1/GIP Receptor AgonistProduct Name: BGM0504 Injection GLP-1/GIP receptor agonist Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Incretin Analogs BGM0504Product Name: Incretin Analogs BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Semaglutide Weight Loss TabletsProduct Name: Semaglutide weight loss tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progressread more
-
Argatroban InjectionProduct Name: Argatroban Injection Cas. 74863-84-6 Molecular Formula C23H36N6O5S Molecular Weight 508.63 Appearance White to off-white powderread more
-
Micafungin Sodium InjectionProduct Name: Micafungin Sodium Injection Cas. 208538-73-2 Molecular Formula C56H72N9NaO23S Molecular Weight 1294.28 Appearance White or off-white solidread more
-
Eribulin Mesylate InjectionProduct Name: Eribulin Mesylate Injection Cas. 441045-17-6 Molecular Formula C41H63NO14S Molecular Weight 826.01 Appearance Colorless liquidread more
-
Oseltamivir Phosphate Suspension and CapsuleProduct Name: Oseltamivir Phosphate Suspension and Capsule Cas. 204255-11-8 Molecular Formula C16H31N2O8P Molecular Weight 410.4 Appearance White to off-white powder Storage Sealed,read more
-
Tiotropium Bromide SMIProduct Name: Tiotropium Bromide Cas. 136310-93-5 Molecular Formula C19H22BrNO4S2 Molecular Weight 472.42 Appearance White or off-white powderread more
-
Tiotropium Bromide and Olodaterol Hydrochloride SMIProduct Name: Tiotropium Bromide and Olodaterol Hydrochloride Appearance Colorless liquidread more
-
Octreotide Acetate LAR InjectionProduct Name: Octreotide Acetate LAR Injection Cas. 83150-76-9 Molecular Formula C49H66N10O10S2 Molecular Weight 1019.24 Appearance Colorless liquidread more
-
Minocycline Hydrochloride LAR InjectionProduct Name: Minocycline Hydrochloride LAR Injection Cas. 13614-98-7 Molecular Formula C23H28ClN3O7 Molecular Weight 493.94 Appearance Yellow crystalline powderread more
WEBAug 12, 2024 · In animal studies, dual GLP-1 and GIP coagonists synergistically reduced fat mass and improved metabolic profiles superior to selective GLP-1 agonist, contrary to selective GIP...
WEB6 days ago · The superior efficacy of tirzepatide, particularly at the 15 mg dose, is consistent with its dual mechanism of action as both a GLP-1 and GIP receptor agonist,...
WEBMay 14, 2024 · Exploring and Managing GLP-1 Receptor Agonists in Weight Loss. Guiding Obesity Management by Understanding Weight Loss Drugs. Glucagon-like...
WEBJul 24, 2024 · Tirzepatide, a dual GIP/GLP-1 receptor agonist, has emerged as a promising therapy for type 2 diabetes. This study aimed to compare the effects of bariatric surgery,...
WEBAug 22, 2024 · A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nat. Metab. 6 ,...
WEBAug 19, 2024 · I provide details regarding the development of GLP-1 receptor agonists for anti-obesity therapy and discuss the possible mechanism behind their beneficial effects...
